Therefore, a new basis for diagnosing both adult and pediatric acute ... clinical patient samples. Different leukemia samples were tested, including acute myeloid leukemia (AML), APL, T- and ...

Your family doctor might refer you to an oncologist or hematologist-- specialists who diagnose and treat leukemia. The doctor will do tests to find out if you have AML and which type you have.

Our research group focuses on forecasting the treatment responses in acute myeloid leukemia - the most common leukemia in adults. These methods are developed in on-going prospective clinical trials to ...

Some popular synthetic hair products used for braids, twists and extensions may contain cancer-causing chemicals and high ...

Acute myeloid leukemia (AML) is the most common blood and bone marrow cancer in adults. Caused by an increase in immature cells that rapidly destroy and replace healthy blood cells (red and white ...

By Daniella Parra Ascentage Pharma (NASDAQ: AAPG; HKEX) said that its drug Olverembatinib is the first China-approved ...

Dasatinib is prescribed for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (CML) in adults.

Revuforj® (revumenib) net product revenue in initial five weeks of launch – – Launched Niktimvo™ (axatilimab-csfr) in the U.S. in late January, in partnership with Incyte – – sNDA filing for revumenib ...

The “off-the-shelf” CAR T-cell therapy CTD402 will be evaluated in a phase 1b/2 trial for patients with T-cell acute ...

Meanwhile, a New Drug Application (NDA) for another one of Ascentage Pharma’s key drug candidates, the novel Bcl-2 selective inhibitor lisaftoclax (APG-2575), has already been accepted and granted the ...